INTRODUCTION
Radiation protection standards, as set forth by a host of regulatory bodies, are based on the uniformity of response of the human population to radiation, and a completely linear relationship between cancer incidence and absorbed dose. Controversy over deviation from this linear relationship at lower doses has culminated in calls for additional scrutiny of biological responses at lower doses (1) . A gathering body of evidence has begun to accrue in support of two separate radiation response biologies: one response program functioning at higher doses, and a separate response program functioning at lower doses (2) (3) (4) . At present, it is not clear whether such considerations will increase or decrease cancer risks at low doses compared with the linear, no-threshold convention.
Determination of cancer incidence in response to radiation at lower doses is further confounded by known variation in the sensitivity of humans to radiation. Increases in radiosensitivity are associated with homozygous loss of function mutations in genes associated with tumor suppression, DNA repair and DNA damage sensing. Among the best studied genes are ATM and TP53 that give rise to A-T or Li-Fraumeni syndromes in humans, respectively. Both of these disorders are characterized by increased radiation sensitivity and cancer incidence (5) (6) (7) . Thus, genotypes of various individuals determine, to a large degree, the variable response to cytotoxic stress.
The effect of hemizygosity resulting in protein haploinsufficiency and the effect of combined hemizygocity is also well established, but its mechanisms are less clear. The loss of a single copy of a radioresistance gene and the combined loss of 2 genes can generate clinically important effects (8) (9) (10) (11) (12) (13) (14) . Existing reports from the literature suggest that contributions to radiosensitivity and tumor formation can be additive in studies examining the interaction between BRCA1 and PTEN (15), as well as Artemis and ATM (16) . Working in mouse model systems, our laboratory has previously demonstrated that haploinsufficiency of 3 radioresistance genes involved in DNA repair and the cell cycle, ATM, Mrad9 and BRCA1, can cause increased radiation sensitivity exhibited in both stochastic and deterministic end points (17) (18) (19) (20) (21) . Given the association of haploinsufficiency with these intermediate phenotypes, an obvious question is: what is the contribution of combined haploinsufficiency of 2 ostensibly silent alleles to radiosensitization and cell cycle checkpoint control? To answer this question, we chose to measure G 2 /M arrest kinetics to assess checkpoint function and accompanying radiation sensitivity in the context of combined haploinsufficiency. The proportion of individuals that are heterozygous for some of these genes is significant: the estimated number of ATM heterozygous individuals accounts for 1-3% of the U.S. population (22) . We therefore chose to investigate the impact of haploinsufficiency for ATM, Mrad9 and PTEN on cell cycle control after radiation induced damage. Inclusion of PTEN was based on its dramatic haploinsufficiency phenotype in mice and reported physical interactions with elements of the checkpoint machinery (23) (24) (25) (26) (27) . Inclusion of Mrad9 was based on its prominent role in radiation response, as well as a reported change in its methylation status commensurate with checkpoint function (28) (29) (30) (31) . Together, genes included in this work have a common role in cell cycle checkpoint control, and are involved in signaling to several downstream biological effectors of the radiation response capable of inducing transformation and apoptosis. Given the differences in Atm null and Pten null phenotype severity, we considered that differences may carry over into the threshold of checkpoint activation that may be evident at lower doses, but, in the context of large amounts of DNA damage, might otherwise be obscured at higher doses.
In addressing the impact of haploinsufficiency on cell cycle control, we considered that the most prominent checkpoint engagement in response to radiation is at the G 2 / M threshold. Further, this checkpoint is comprised of two co-functioning components: one preventing transition from the G 2 /M compartment into mitosis, and a second blocking those cells from late G 1 and S phase from completing mitosis (32) . The threshold of checkpoint activation is also important as some cells will carry damage through the checkpoint to die subsequently in mitotic catastrophe (33) .
The goals of this work were to assess rapidly dividing, minimally perturbed cell populations with combined haploinsufficiency for ATM, Mrad9 and PTEN, for their ability to halt at the G 2 /M checkpoint after irradiation with low and high doses. In so doing, we sought to test whether the radiosensitivity shown to accompany combined haploinsufficiency is coincident with the checkpoint control functions of these genes. In the context of partially ablated checkpoint components in various combinations, we also sought to gain more detailed mechanistic insight into checkpoint function, especially at low doses.
MATERIALS AND METHODS

Mouse Embryo Fibroblasts
Animals were handled per a protocol approved by the Columbia University Institutional Animal Care and Use Committee. Animals heterozygous for Pten were the kind gift of Dr. Ramon Parsons. Atm heterozygous mice, constructed in the Wynshaw-Boris laboratory (129S6/SvEvTac-ATM tm1Awb /J), were sourced from Jackson Laboratories (34, 35) . Mice defective in Mrad9 were constructed previously in Dr. Lieberman's laboratory (29) . Fibroblasts were generated by sacrificing pregnant females on days 14 and15 after pairing and digesting dissected embryos in 0.25% trypsin (Mediatech, Manassas, VA) for 10-15 min at 378C (19) . Genotyping of cells and embryos was conducted by PCR performed on proteinase K digests of cells or tissues using primers appropriate for each radioresistance gene. Sequences for primers were drawn from the literature or were available from commercial purveyors of animals. Resultant mouse embryo fibroblasts were seeded in 10 cm culture plates in DMEM (Mediatech) containing 15% fetal bovine serum (Gemini, West Sacramento, CA) supplemented with 100 U/mL penicillin/streptomycin (Mediatech, Manassas, VA). Cells were permitted to expand over several days, were trypsinized and then seeded in a T175 tissue culture flask until confluent. Cells were harvested from confluent T175 dishes at this stage for experiments. Fibroblasts were maintained in a humidified incubator at 378C and 5% CO 2 and were fed 3 times per week.
Irradiation
Cells were placed in insulating material to prevent temperature shock and were irradiated in a Gammacell 40 apparatus (Atomic Energy, Ontario). The dose rate from the 137 Cs source was 0.79 Gy/ min. For lower doses, below 0.1 Gy, lead plates were placed between the source and specimen, which reduced the dose rate to 0.33 Gy/min.
Cell Cycle Measurements
Mouse embryo fibroblasts were seeded in 6 well plates at a density of 22 3 10 3 cells/cm 2 and were cultured, undisturbed, for 42-48 h, which resulted in a subconfluent, actively dividing population at the time of irradiation. At specified time intervals after irradiation, cells were trypsinized and pelleted. Pellets were resuspended in 300 lL PBS and then supplemented with 800 lL of chilled (48C) 100% EtOH before subsequent incubation at À208C overnight. Fixed cells were again pelleted and resuspended in 250 lL PI/RNAse solutions (BD Biosciences, Bedford, MA) and allowed to stand at room temperature for 2 h. Resultant samples were processed by flow cytometry (Facscalibur, BD). Sample collection was programmed to end after collection of 3 3 10 4 events. Aggregates and doublets were omitted from analysis. The profiles of retained events were processed through ''Watson Pragmatic'' population modeling algorithm within the Flowjo software suite that provided fractions of G 1 , S and G 2 /M. Some samples were lost due to handling errors and in those instances all remaining available samples were used in the reporting of means and standard deviation.
Tests for Statistical Significance
All assessment for statistical significance was conducted between two groups (sham and irradiated) using a two tailed Student's t test. Differences were deemed significant when acquired P values were equal to or less than 0.05.
RESULTS
Reciprocal, Asynchronous Component Engagement at the G 2 /M Checkpoint in Freshly Prepared Mouse Embryo Fibroblasts
The radiation-activated G 2 /M checkpoint is comprised of two components that are measured in two different ways. The first component is located at the juncture between G 2 and M phases of the cell cycle, and is examined by assessing the phosphorylation status of histone 3A, a marker of mitotic cells (36) . The second component, reporting the behavior of a larger number of cells, is measured by conventional propidium iodide staining for ploidy and is monitored by assessment of changes in the 4N population, where N is the haploid content of DNA in the cell. This ploidy content assessment will contain the population at the brink of G 2 to M transition, and will also contain those cells arresting in G 2 that are arriving with radiation induced damage from late G 1 and S phases of the cell cycle (32) . We find that freshly isolated mouse embryo fibroblasts exhibit correct function of both components of the G 2 /M checkpoint in a reciprocal, dose-dependent fashion. Observed changes in the fraction of H3-P-positive cells reveal a prominent, relatively early cessation of mitosis evident at 2 h after irradiation that subsequently resolves over the remaining 10 h course (Fig. 1A) . The fraction of cells with 4N ploidy increases concomitantly with a G 2 /M arrest, which peaks 6-8 h after irradiation. In actively dividing, wild type mouse embryo fibroblasts, this second component resolves subsequently over the remainder of the time course (Fig. 1B) . At the greatest dose used in the study, 5.0 Gy, the maximum arrest shifts to 8 h after irradiation. Cell populations treated with this higher dose also fail to resolve the G 2 /M arrest fully to baseline levels by the completion of the time course. Mouse embryo fibroblasts maintained a fairly constant level of cells present in G 2 /M from 42-48 h after seeding with a slight decay in that population fraction in the 12 h surveillance period thereafter (Fig. 1C) . The focus of the remaining comparisons in this work is limited to the changes in the 4N population, of which the Histone 3 phosphorylation positive population is a subset.
Checkpoint Activation Threshold
The impact of low and high doses of radiation on cell cycle progression was studied in actively cycling mouse embryo fibroblasts. Doses of 10, 50 and 100 mGy were used for the low dose experiments, and doses of 0.5, 1.0 and 5.0 Gy were used for high dose studies. Fibroblasts were seeded, permitted to recover and then subjected to irradiation and fixed for cell cycle analysis.
Wild type mouse embryo fibroblasts isolated from heterozygous Atm pairings recapitulated the 6-8 h maximal arrest with 5.0 Gy, while lower 0.5 and 1.0 Gy doses caused a slight shift in the curve to a maximal arrest closer to 6 h (Fig. 2B) . Cells derived from Atm null embryos failed to mount a robust G 2 /M arrest in response to 5.0 Gy irradiation (Fig. 2D) . Counter to observations in other biological (Fig. 2C) .
Given that lower doses generated maximum arrest responses at 6 h after irradiation, detailed low dose comparisons over the range of 0-100 mGy were conducted at this point. In accordance with trends observed at higher doses, checkpoint induction was absent in mouse embryo fibroblasts null for Atm over this low dose range. Notably, no significant increase in G 2 /M fraction was observed in wild type mouse embryo fibroblasts or those haploinsufficient for ATM (Fig. 3A) . Cells with combined haploinsufficiency for ATM and PTEN showed no significant induction in the G 2 /M population over the low dose range of interest (Fig. 3B) . Throughout the time courses, G 1 and S phase populations were also examined, but the most robust findings were seen at the G 2 /M checkpoint (see Supplementary Figures: RR10.1667/RR2875.1.S1).
Impact of Combined Haploinsufficiency on Radiation Induced Cell Cycle Checkpoint Control
To further probe differences in checkpoint function, doses between 0.5 and 5.0 Gy were used on mouse embryo fibroblasts with combined haploinsufficiency for PTEN, ATM and Mrad9 based on previously demonstrated known interactions with the G 2 /M checkpoint apparatus. Wild type mouse embryo fibroblasts derived from littermates over various F 1 pairings reproducibly mounted a characteristic 6 h maximum arrest, except when doses increased to 5.0 Gy where the arrest maximum was delayed until 8 h after irradiation and resolution of the arrest did not complete by the end of the 12 h course (Fig. 4A-C) . Mouse embryo fibroblasts that were combinatorially haploinsufficient for two radioresistance proteins exhibited no significant deviation as compared to mouse embryo fibroblasts from wild type littermates (Fig. 4D-F) .
DISCUSSION
Examples from the literature show that complete loss of radioresistance gene function involved in DNA doublestrand break repair can impart increased cancer incidence in humans and, when deleted in mice, can generate very severe, early embryonic lethal phenotypes (5, 6, 24, 25, 35, 37) . Individuals who are heterozygous for radioresistance genes could harbor greater sensitivity to radiation damage. Clinical studies show that relatively small changes in nonhomologous end-joining genes are also associated with increased risk of cancers (14, 38, 39) . Furthermore, a series of studies implicates radiosensitizing haploinsufficiency and combined haploinsufficiency in a variety of biological end points, including radiation induced cataract formation, apoptosis and transformation (9, (17) (18) (19) (20) (21) . In that previous work, we show that mouse embryo fibroblasts haploinsufficient for both ATM and Mrad9 are more sensitive to transformation induced by radiation. These same mouse embryo fibroblasts show different dynamics of doublestrand break repair. Thymocytes haploinsufficient for both ATM and Mrad9 exhibit less apoptosis than wild type cells or those haploinsufficient for only one of the encoded proteins (18) . Our in vivo studies demonstrated that animals heterozygous for both Atm and Mrad9 exhibit intermediate onset rates in cataractogenesis in comparison to wild type and nullizygous litter mates (17, 18) . Based on these preliminary studies, we anticipated defects in G 2 /M arrest kinetics in mouse embryo fibroblasts with combined haploinsufficiency for ATM and Mrad9.
In the current study we observe statistically significant increases in the G 2 /M fraction of mouse embryo fibroblasts doubly haploinsufficient for ATM and PTEN at doses above 0.5 Gy. We do not see a statistically significant change in the G 2 /M fraction over the dose range of 0-100 mGy. This threshold for activation between 100 and 500 mGy is also observed by other laboratories studying checkpoint function (12, 32) . This threshold seems to represent the lowest threshold of damage that is tolerated for subsequent release from the checkpoint (16, 40) . The significant and unique finding presented here is that the activation of all cell cycle checkpoints occurs irrespective of haploinsufficiency contributed by various combinations of radioresistance genes when examined in freshly isolated mouse embryo fibroblasts after acute exposures to c radiation. The G 2 /M checkpoint, irrespective of haploinsufficiency in mouse embryo fibroblasts, engages at a threshold greater than 0.1 Gy and less than 0.5 Gy.
The strengths of the study include the use of an asynchronous, rapidly dividing population of embryonic cells that contains a very large S-phase population that is continually feeding into the G 2 /M checkpoint. The cells employed were not immortalized or transformed and therefore have no exogenously applied factors that interfere with cell cycle components by introducing genotoxic stress that could otherwise bias results (41) . Sample sizes and technical iterations were both large (here, 30 3 10 3 cells per sample, 3 to 6 iterations), affording greater resolving power in examining smaller changes assessed at lower doses.
The genes selected for study, Atm, Mrad9 and Pten, had been extensively examined for their functions in maintaining genomic stability and DNA repair. ATM is a serine/ threonine protein kinase and a member of the phosphoinositide 3-kinase-related protein kinase family of kinases, functioning as a sensor/transducer in the DNA damage response. ATM is involved in the initial response to DNA double-strand breaks, binding to the MRN (Mre11, Rad50, NBS1) heterotrimer at double-strand breaks, then becoming subsequently activated. The activated ATM induces downstream signaling and subsequent activation of DNA repair, checkpoint control and apoptosis. Atm knockout mice develop progressive cerebellar ataxia, lymphoma and leukemia (42) . ATM-deficient cells are characterized by chromosomal instability and hypersensitivity to ionizing radiation (19, 28) .
The rad9 gene was first identified in S. pombe as an element conferring sensitivity to UV and ionizing radiation when mutated. The mouse homolog of rad9, when deleted, was found to impart aberrant apoptosis and impaired G 2 /M checkpoint control (29) (30) (31) . Furthermore, aberrant expression of the human gene is associated with a variety of cancers (28, 43) .
Mutations in the PTEN tumor suppressor gene are associated with spontaneous breast cancer incidence in women (44) . PTEN is of interest in radiotherapy because heterozygosity can impart cytogenetic instability and compromised cell cycle control (45, 46) . Furthermore, PTEN features prominently in a breast cancer initiation model downstream of BRCA1 (47) . Evidence supporting PTEN haploinsufficiency as a contributing factor in oncogenesis comes from several studies and appears to include inappropriate activation of survival signaling. While mice that are nullizygous for Pten exhibit a very severe, early embryonic lethality, heterozygous animals survive less than 60 weeks and exhibit susceptibility to tumor development together with hyperplastic and neoplastic proliferative disorders in several tissues (23-25, 48, 49) . The severe effects of single gene copy changes in PTEN are further exemplified by its additive contributions to malignancy when expressed in mouse models, where cancer is promoted by the presence of either MMTV integration or SV40 T antigen expression in murine tissues (49, 50) .
There is evidence to support the interplay among radioresistance genes in the context of a productive DNA damage response acting at various points in the cell cycle. ATM induces G 2 /M arrest by phosphorylation of BRCA1 on serine 1423, and CHK2 on threonine 63 (5). ATM also exerts control at the G 1 /S boundary via phosphorylation of TP53, MDM2, and CHK2, which may inhibit the Cyclin-E/ CDK2 complex. Consider also that Mrad9 participates in the G 1 checkpoint activation where it is phosphorylated by ATM at Serine 272. Additionally, Mrad9 interacts with protein arginine methyltransferase 5 (PRMT5), resulting in the methylation of Mrad9 arginines 172, 174, and 175 in the glycine-arginine rich sequence. Arginine methylation of Mrad9 is required for G 2 /M cell cycle checkpoints function (28) . Finally, expression of cell cycle regulators Cdc25a, E2F2, cyclin G 2 , and RBL2/p130 that are important in G 1 growth arrest appear to be dependent on PTEN (51) . The interdependent role in cell cycle regulation of ATM and Mrad9, and the role of PTEN in G 1 cell cycle arrest, suggest that haploinsufficiency for these proteins may affect their control of cell cycle progression as it was shown for other processes.
Together, our findings suggest that there is not a discernible connection between the radiosensitivity that arises from haploinsufficiency in our other systems of study and the control of the G 2 /M checkpoint. Moreover, a substantial dose, coincident with a significant amount of DNA damage, must be applied for activation of the checkpoint. This means that there is essentially no detectable checkpoint at low doses. Activation of the checkpoint only occurs at doses where most of the cells that are bound for mitotic catastrophe are reproductively dead. Lastly, our findings confirm a threshold of activation for the G 2 /M checkpoint, hinting at two separate radiation response programs acting below and above this threshold.
